Nautilus Biotechnology (NAUT)
(Real Time Quote from BATS)
$2.75 USD
-0.02 (-0.72%)
Updated May 23, 2024 10:24 AM ET
2-Buy of 5 2
D Value F Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.15 |
Last EPS Surprise | 6.25% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.68 |
Next Year | -0.80 |
EPS (TTM) | -0.55 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 9.69M |
# of Estimates | NA | NA | NA | 2 |
High Estimate | NA | NA | NA | 15.60M |
Low Estimate | NA | NA | NA | 3.78M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.18 | -0.68 | -0.80 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.15 | -0.17 | -0.67 | -0.79 |
Low Estimate | -0.16 | -0.18 | -0.68 | -0.81 |
Year ago EPS | -0.13 | -0.13 | -0.51 | -0.68 |
Year over Year Growth Est. | -23.08% | -38.46% | -33.33% | -18.38% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.18 | -0.68 | -0.80 |
7 Days Ago | -0.16 | -0.18 | -0.68 | -0.80 |
30 Days Ago | -0.17 | -0.19 | -0.72 | -0.82 |
60 Days Ago | -0.17 | -0.19 | -0.72 | -0.82 |
90 Days Ago | -0.19 | -0.19 | -0.73 | -0.79 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.18 | -0.68 | -0.81 |
Zacks Consensus Estimate | -0.16 | -0.18 | -0.68 | -0.80 |
Earnings ESP | 0.00% | 0.00% | -0.74% | -1.25% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.15 | -0.14 | -0.13 | -0.13 | NA |
Estimate | -0.16 | -0.16 | -0.18 | -0.17 | NA |
Difference | 0.01 | 0.02 | 0.05 | 0.04 | 0.03 |
Surprise | 6.25% | 12.50% | 27.78% | 23.53% | 17.52% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more